CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||
| Sales | $ 16,640 | $ 0 | $ 16,640 | $ 0 |
| Operating expenses: | ||||
| General and administrative | 1,527,699 | 394,654 | 5,182,358 | 1,131,662 |
| Research and development | 20,357 | 0 | 217,229 | 79,550 |
| Facility operations | 398,504 | 154,470 | 810,260 | 234,113 |
| Depreciation | 218,134 | 18,173 | 830,409 | 37,850 |
| Amortization | 367,500 | 0 | 514,000 | |
| Total operating expenses | 2,532,194 | 567,297 | 7,554,256 | 1,483,175 |
| Net loss from operations | (2,515,554) | (567,297) | (7,537,616) | (1,483,175) |
| Other income (expense): | ||||
| Interest expense | (80,991) | (42,541) | (228,190) | (102,057) |
| Amortization of debt discount | (340,000) | 0 | (576,364) | 0 |
| Financing costs | (1,393,000) | 0 | (1,502,953) | (64,452) |
| Change in fair value of derivative liability | 0 | 0 | 0 | (29,000) |
| Change in fair value of warrant liability | (137,000) | 0 | (137,000) | 0 |
| Forgiveness of PPP loan | 0 | 0 | 103,200 | 0 |
| Gain on Vero Blue note settlement | 500,000 | 0 | 500,000 | 0 |
| Legal Settlement | (29,400,000) | 0 | (29,400,000) | 0 |
| Total other income (expense) | (30,850,991) | (42,541) | (31,241,307) | (195,509) |
| Loss before income taxes | (33,366,545) | (609,838) | (38,778,923) | (1,678,684) |
| Provision for income taxes | 0 | 0 | 0 | 0 |
| Net loss | (33,366,545) | (609,838) | (38,778,923) | (1,678,684) |
| Less net loss attributable to non-controlling interest | 0 | (1,074) | 0 | (4,655) |
| Net loss attributable to NaturalShrimp Incorporated | (33,366,545) | (608,764) | (38,778,923) | (1,674,029) |
| Amortization of beneficial conversion feature on Preferred shares | 0 | (443,333) | (817,376) | (1,543,333) |
| Redemption and exchange of Series D Preferred shares | 0 | (5,792,947) | 0 | |
| Dividends | 0 | (172,291) | 0 | (317,083) |
| Net loss available for common stockholders | $ (33,366,545) | $ (1,224,388) | $ (45,389,246) | $ (3,534,445) |
| EARNINGS PER SHARE (Basic and diluted) | $ (0.05) | $ (0.00) | $ (0.07) | $ (0.01) |
| WEIGHTED AVERAGE SHARES OUTSTANDING (Basic and diluted) | 635,536,459 | 451,549,772 | 608,191,555 | 419,177,832 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash outflow for loan and debt issuance costs. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Facility expenses incurred related to gas and oil produced and sold during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|